Silexion Therapeutics Corp (SLXN) concluded trading on Wednesday at a closing price of $1.56, with 6.47 million shares of worth about $10.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -98.52% during that period and on January 15, 2025 the price saw a loss of about -11.86%. Currently the company’s common shares owned by public are about 1.24M shares, out of which, 1.04M shares are available for trading.
Stock saw a price change of -25.71% in past 5 days and over the past one month there was a price change of -53.29%. Year-to-date (YTD), SLXN shares are showing a performance of -22.39% which decreased to -98.29% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.75 but also hit the highest price of $122.02 during that period. The average intraday trading volume for Silexion Therapeutics Corp shares is 916.54K. The stock is currently trading -29.73% below its 20-day simple moving average (SMA20), while that difference is down -36.77% for SMA50 and it goes to -96.92% lower than SMA200.
Silexion Therapeutics Corp (NASDAQ: SLXN) currently have 1.24M outstanding shares and institutions hold larger chunk of about 8.09% of that.
The stock has a current market capitalization of $2.50M and its 3Y-monthly beta is at 0.03. It has posted earnings per share of -$19.71 in the same period. It has Quick Ratio of 0.85. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for SLXN, volatility over the week remained 16.37% while standing at 18.10% over the month.
